Cargando…

Efficacy and safety of methotrexate treatment of juvenile localized scleroderma

Detalles Bibliográficos
Autores principales:	Osminina, MK, Geppe, NA, Tougarinova, GV, Rabieva, GM, Kostina, YO
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2008
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3334035/ http://dx.doi.org/10.1186/1546-0096-6-S1-P230

Ejemplares similares

Anti-tumor necrosis factor therapy in children with refractory Takayasu arteritis: report of five cases
por: Kostina, YO, et al.
Publicado: (2011)

Long-term methotrexate efficacy in juvenile localized scleroderma
por: Zulian, F, et al.
Publicado: (2011)

Mycophenolate Mofetil in severe or methotrexate refractory localized scleroderma
por: Martini, G, et al.
Publicado: (2008)

Juvenile localized scleroderma: review of 44 patients
por: Iglesias, E, et al.
Publicado: (2011)

Localized scleroderma in a cohort of juvenile idiopathic arthritis children
por: Giani, Teresa, et al.
Publicado: (2014)

Infectious agents in juvenile scleroderma
por: Chyzheuskaya, Iryna, et al.
Publicado: (2014)

Extracranial linear localized scleroderma associated with longstanding epileptic encephalopathy unresponding to methotrexate and prednisone
por: Rigante, D, et al.
Publicado: (2008)

Mycophenolate mofetil for methotrexate-resistant juvenile localized scleroderma
por: Martini, Giorgia, et al.
Publicado: (2020)

The frequency of pulmonary hypertension in juvenile scleroderma
por: Adrovic, Amra, et al.
Publicado: (2014)

Reliability of using an ultrasound scoring measure for juvenile localized scleroderma (jLS)
por: Li, Suzanne C, et al.
Publicado: (2012)

SHARE – workpackage 5: evidence based recommendations for diagnosis and treatment of juvenile localized scleroderma and juvenile systemic sclerosis
por: Culpo, Roberta, et al.
Publicado: (2014)

PReS-FINAL-2120: Juvenile scleroderma international network (JUSINET) database: a reliable instrument for clinical research in juvenile scleroderma syndromes
por: Cuffaro, G, et al.
Publicado: (2013)

Developing juvenile localized scleroderma (jLS) consensus treatment regimens for comparative effectiveness studies
por: Li, Suzanne C, et al.
Publicado: (2012)

The prospective juvenile systemic sclerosis inceptions cohort – http://www.juvenile-scleroderma.com
por: Foeldvari, I, et al.
Publicado: (2008)

Update on the juvenile systemic sclerosis inception cohort http://www.juvenile-scleroderma.com
por: Foeldvari, Ivan, et al.
Publicado: (2014)

Efficacy of oral versus subcutaneous methotrexate in children with juvenile idiopathic arthritis
por: Tzaribachev, N, et al.
Publicado: (2008)

Genetic determinants of methotrexate treatment efficacy in patients with juvenile idiopathic arthritis
por: Avramovič, Mojca Zajc, et al.
Publicado: (2014)

Description of the localized scleroderma subgroup of CARRAnet
por: Wu, Eveline, et al.
Publicado: (2012)

Methotrexate in oligoarticular persistent juvenile idiopathic arthritis
por: Horneff, Gerd, et al.
Publicado: (2014)

PReS-FINAL-2119: United Kingdom survey of current management of juvenile localised scleroderma
por: Hawley, DP, et al.
Publicado: (2013)

Immunomodulatory actions of methotrexate on T cells in juvenile idiopathic arthritis
por: Ćalasan, Maja Bulatović, et al.
Publicado: (2012)

PReS-FINAL-2128: Quality of life and psychosocial aspects in juvenile localized scleroderma (JLS): a cross-sectional study in 40 patients
por: Culpo, R, et al.
Publicado: (2013)

PReS-FINAL-2124: Electromyography assessment in localized scleroderma
por: Fernandes, TP, et al.
Publicado: (2013)

Prediction of methotrexate efficacy and adverse events in patients with juvenile idiopathic arthritis: a systematic literature review
por: Van Dijkhuizen, Pieter, et al.
Publicado: (2014)

Experience of the concentration of methotrexate evaluation in children with juvenile idiopathic arthritis
por: Rokhlina, FV, et al.
Publicado: (2011)

Methotrexate restores effector T cell responsiveness in juvenile idiopathic arthritis
por: Bulatović, Maja, et al.
Publicado: (2011)

Reasons for stopping methotrexate treatment in patients with juvenile idiopathic arthritis
por: Carolina Da Silva, Ana, et al.
Publicado: (2014)

Study about evaluation of efficacy of methotrexate in localized scleroderma using ultrasonography
por: Zhang, Fan, et al.
Publicado: (2023)

Time to treatment as an important factor for the response to methotrexate in juvenile idiopathic arthritis
por: Albers, HM, et al.
Publicado: (2008)

Prediction of clinical non-response to methotrexate treatment in juvenile idiopathic arthritis
por: Van Dijkhuizen, EH Pieter, et al.
Publicado: (2011)

Histopathological and molecular analysis in dermis and epidermis of patients with systemic and localized scleroderma
por: Sozeri, Betul, et al.
Publicado: (2014)

MTHFR polymorphism and red cell folate levels are not useful as biomarkers of methotrexate efficacy and toxicity in children with juvenile idiopathic arthritis
por: Tuková, J, et al.
Publicado: (2008)

Influence of Reduced Folate Carrier and Aminoimidazole Carboxamide Ribonucleotide Transformylase gene polymorphisms on the efficacy of methotrexate in juvenile idiopathic arthritis
por: Bilginer, Yelda, et al.
Publicado: (2011)

Efficacy and safety of Etanercept therapy in juvenile idiopathic arthritis
por: Lazareva, Arina, et al.
Publicado: (2011)

PReS-FINAL-2165: Pharmacogenetic determinants of response to methotrexate in juvenile idiopathic arthritis
por: Pastore, S, et al.
Publicado: (2013)

PReS-FINAL-2048: Treatment with methotrexate plus leflunomide for juvenile idiopathic arthritis
por: Quesada-Masachs, E, et al.
Publicado: (2013)

Takaysu arteritis treatment in children
por: Kostina, YO, et al.
Publicado: (2014)

Retrospective audit of access to care for children and young people diagnosed with localised scleroderma or juvenile systemic sclerosis in the United Kingdom
por: Hawley, Daniel P, et al.
Publicado: (2012)

Safety and efficacy of tocilizumab in children with systemic juvenile idiopathic arthritis
por: Horneff, G, et al.
Publicado: (2015)

PReS-FINAL-2155: Genetic variability of methotrexate transporters in patients with juvenile idiopathic arthritis
por: Zajc Avramovič, M, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_rdrkjog0aaea3d5ge9tosa1pof